Let’s provoke thought, spark discussion, & keep pace with how technology can advance healthcare.
As Healthcare's Digital Dawn rises, we are experiencing a new kind of pandemic.
Not driven by a virus, but by AI, data democratization, scientific advancement, and exponential technological adoption.
Despite the extraordinary pace of AI adoption and advancement in healthcare, we're still in Phase I. There is far more ahead of us than behind us, and we are nowhere near anything resembling herd immunity to the scale of change that is coming.
Yet this moment is less about containing spread and more about building the capability, trust, and fluency needed for society to benefit from this new therapeutic class—AI—responsibly and at scale.
The Pandemic of Change has already begun.
If you're feeling restless right now—good. It means you're paying attention.
Since launching Dose of Innovation, I've spoken with executives, innovators, and clinicians around the world. Different roles. Different industries. Different geographies.
Yet they all describe the same underlying feeling: restlessness. This restlessness isn't random. It's the natural response to the Pandemic of Change.
When the pace of external change exceeds your internal capacity to absorb it—that creates restlessness. When you can see the future clearly but can't yet chart a trusted path forward—that creates restlessness.
But what if restlessness isn't a problem to solve? What if it's a leadership trait to cultivate?
Restlessness exists for a reason. Digital progress is no longer linear—it is exponential. Innovation roadmaps created just a year ago can already feel outdated.
Healthcare leaders must learn to operate with confidence amid the velocity of the Pandemic of Change. The familiar rhythms of business as usual may no longer serve us.
Perhaps the new normal is Business Unusual. A world where learning matters more than knowing. Where momentum matters more than mastery. Where boldness increasingly beats certainty.
The rulebook for who gets to innovate has changed too. Patients, clinicians, and partners are no longer spectators. They are innovators, competitors, and co-creators.
If you're not learning fast, adapting faster, and building in motion, you may already be behind. Welcome to Business Unusual.
Business Unusual demands a different approach from leaders.
In responding to the Pandemic of Change, it's important to remember that even the most transformative therapy can fail if the dosing is wrong. Because in healthcare, adoption matters as much as innovation.
The therapeutic window of opportunity is wide open—but flooding an organization with change rarely accelerates transformation. More often, it creates resistance and amplifies the most unproductive form of restlessness.
If innovation were a medicine, we'd dose it wisely. Technology may move at digital speed, but people adopt change at human speed.
Sustainable transformation isn't achieved through a single breakthrough. It's achieved through a continuous innovation infusion.
Recognizing the Pandemic of Change is not enough.
Restlessness must be channeled. Business Unusual must be embraced. Innovation's Potent Therapy must be delivered with purpose and precision.
That is the role of the Dose Escalation Playbook. A practical framework designed to help healthcare leaders respond with urgency, adapt with confidence, and build a continuous innovation infusion.
The Playbook is built around four essential strategies: Ride the Innovator's Slipstream | Join the Democratization Movement | Embrace Contrarian Wisdom | Win Hearts, Widen Ripples.
Because in a world where hesitation may cost more than risk, the leaders who learn fastest, adapt fastest, and inspire others to move with them will help shape what comes next.
FOUNDER, DOSE OF INNOVATION
Behind Dose of Innovation is Alex Condoleon, a healthcare executive, innovator, and lifelong student of leadership, innovation, and change.
Through articles, frameworks, and Dose Response conversations, Alex explores the ideas, emerging technologies, and transformational shifts reshaping healthcare—translating complex trends into practical insights for leaders navigating an increasingly dynamic world.
His work sits at the intersection of healthcare, technology, leadership, and human behavior, with a particular focus on helping organizations move from possibility to adoption and from innovation to impact.
Because we're still in Phase I.